Pune, India, September, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on Companion Animal Healthcare Market Research Report.
Market Research Future (MRFR)’s latest study has revealed that the global companion animal healthcare market is poised to proliferate rapidly at a CAGR of 9.6% during the forecast period 2017 to 2023. The market is set to grow from USD 14 Bn in 2016 to USD 20 Bn in 2023. The growing trend of pet adoption is likely to fuel demand in the companion animal healthcare market as it provides a sense of belongingness and responsibility to the people. The exponential geriatric population has accelerated the rate of pet adoption in the recent times. The trend is anticipated to perpetuate across the assessment period.
An increase in the expenditure on companion animals coupled with advancements in medicines and vaccinations have fueled the demand in the market. The market resonates strong growth opportunities presently, and the rising per capita income of the population is likely to have a positive influence on the expansion of the companion animal healthcare market.
The increasing inclination of the pet owners towards a healthy lifestyle of their companions is projected to catapult the companion animal healthcare market on an upward trajectory. The growing number of nuclear families has paved the way for a rise in pet adoption and expenditure among the middle-class families, which is prognosticated to favor the growth of the market over the next couple of years.
By product, the global Companion animal healthcare market has been segmented into feed additives, pharmaceuticals, and vaccines.
By diagnostic tests, the companion animal healthcare market is segmented into diagnostic imaging, immunodiagnostic tests, molecular diagnostics, and other tests.
By end-users, the global companion animal healthcare market has been segmented into veterinary hospitals, veterinary clinics, and home care.
By region, the global companion health care animal market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the largest market for companion animal healthcare and is forecasted to exhibit significant growth over the assessment period. The wide range of product offerings for animal healthcare coupled with a great emphasis on the pet health is set to aid market proliferation in the region.
Europe is the second largest regional companion health care animal market. The factors projected to favor the market expansion during the forecast period include tax benefits from governments, rising pet ownership, etc.
The increasing awareness about the animal cruelty is set to provide an impetus to the growth of the Asia Pacific market. Meanwhile, the Middle East & Africa is expected to register slow growth rate while exhibiting immense opportunities for expansion.
Some of the key players profiled in the report are Zoetis Animal Healthcare (U.S.), Merck and Co., Inc. (U.S.), Ceva Animal Healthcare (U.K), Virbac Animal Healthcare (France), Merial (France), Elanco Animal Health (U.S.), Bayer Animal Health (Germany), Vetoquinol S.A. (France), Perrigo Company plc (Ireland), and Boehringer Ingelheim (Germany).
In April 2018, Lancaster witnessed its first mobile veterinary unit, SS Pantry, for vaccines and spay/neuter clinics.
In August 2018, FDA has approved NexGard® (afoxolaner), which prevents the infection that causes Lyme disease in dogs.